Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
34
Number of overlapping holdings
54.0%
% of XLV's 64 holdings also in BMED
26.4%
% of BMED's 147 holdings also in XLV
Overlap by Weight
Sector Drift (XLV minus BMED)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in XLV |
Weight in BMED |
Overlap | |
---|---|---|---|---|
INTUITIVE SURGICAL INC | 2.5% | 2.3% | 2.3% | |
ABBVIE INC | 5.7% | 2.1% | 2.1% | |
BOSTON SCIENTIFIC CORP | 1.9% | 3.5% | 1.9% | |
AMGEN INC | 2.8% | 1.9% | 1.9% | |
ELI LILLY & CO | 11.2% | 1.7% | 1.7% |
Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to BMED
ELI LILLY & CO | 9.6% | |
UNITEDHEALTH GROUP INC | 7.6% | |
JOHNSON & JOHNSON | 6.9% | |
MERCK & CO. INC. | 4.9% | |
THERMO FISHER SCIENTIFIC INC | 4.1% | |
ABBVIE INC | 3.6% | |
ABBOTT LABORATORIES | 2.9% | |
PFIZER INC | 2.9% | |
MEDTRONIC PLC | 2.1% | |
CIGNA CORPORATION | 2.0% |
XLV Underweight Relative to BMED
AMERISOURCEBERGEN CORP | -2.4% | |
NOVO NORDISK A/S-B | -2.1% | |
BIOMARIN PHARMACEUTICAL INC | -1.8% | |
ARGENX SE ADR | -1.8% | |
COOPER COS INC/THE | -1.8% | |
ALIGN TECHNOLOGY INC | -1.6% | |
ALNYLAM PHARMACEUTICALS INC | -1.6% | |
QIAGEN NV | -1.6% | |
BOSTON SCIENTIFIC CORP | -1.5% | |
BLUEPRINT MEDICINES CORP. | -1.5% |